Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,360.80 +222.69 1.47%
Hang Seng 23,493.00 +410.35 1.78%
S&P/ASX 200 5,209.04 +28.26 0.55%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Commercial Services
  • Sub-Industry: Commercial Services

PharmaRoth Labs Inc

FROI:US

Ticker Change

As of 20:10:00 ET on 05/01/2013.

Company Profile for PharmaRoth Labs Inc (FROI)

PharmaRoth Labs, Inc. plans to acquire healthcare related companies, products, and technologies that have large market potential, improve the quality of care, or have unmet needs. The Company main focus is on the medical device, biotechnology, pharmaceutical, nutraceutical, and healthcare IT industries. PharmaRoth produces, markets, and distributes diabetic medications.

Contact Information

PharmaRoth Labs Inc

17 Reeves Crescent
Red Deer, AB T4P 2Z4
Canada
Phone: 1-403-827-7936

Key Executives for PharmaRoth Labs Inc (FROI)

Luis Manuel Ornelas LopezChief Executive OfficerBarry W HallInterim CFO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil